机构名称：
¥ 1.0
1。In May 2017, the Seventieth World Health Assembly, having considered the report on the public health dimension of the world drug problem, 1 adopted decision WHA70(18), 2 in which it requested the Director-General to continue efforts to improve the coordination and collaboration of WHO with UNODC and the International Narcotics Control Board, within their existing mandates, and to report on the implementation of the decision to the Seventy-first, Seventy-third以及第七十五届世界卫生议会，并继续将委员会保留在麻醉药品上，适当地了解相关计划和进步。在2021年5月，在WHA74（17）3的情况下，第七十四个世界卫生大会在WHA治理改革过程中采取了决定，在此决定，除其他外，它的决定，关于理事机构授权的未来报道应获得更高的特异性。
世界药物问题的公共卫生维度
主要关键词
相关文件推荐
